EcoDrugPlus

Ribosomal Protein S7

Ensembl ID : ENSLOCG00000017211
Gene Symbol: RPS7
3 Cross references
357 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSLOCG00000008007
Gene Symbol: RPS9
1 Cross references
232 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSLOCG00000012032
Gene Symbol: RPSA
4 Cross references
516 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSLOCG00000001683
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSLOCG00000007729
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSLOCG00000003294
Gene Symbol: SCTR
2 Cross references
130 Possible Orthologues:

Selectin E

Ensembl ID : ENSLOCG00000001404
Gene Symbol: SELE
1 Cross references
197 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSLOCG00000014384
Gene Symbol: LOC102687735
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSLOCG00000011041
Gene Symbol: LOC102695383
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSLOCG00000000247
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSLOCG00000013088
Gene Symbol: LOC102697879
2 Cross references
585 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSLOCG00000013082
Gene Symbol: LOC102697682
2 Cross references
585 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).